AI wall for Pauni proposed to handle man-animal conflict
Pauni taluka
as the site for the pilot project, because of the increasing incursions of tigers into human habitat.The AI wall is basically a system of cameras set up along a predefined periphery, and when it captures a tiger on screen an alert message is sent to nearby villages.Rahul Gavai, deputy conservator of forest (Bhandara) said, "We are going to propose the AI wall concept to the
District Planning and Development Committee
(DPDC), as the funding for the same will be required."Gavai's plan has the potential to save human lives as the AI wall gives a 'heads up' to villagers, who can then avoid venturing in that particular area.
Get the latest lifestyle updates on Times of India, along with
Mother's Day wishes
,
messages
, and
quotes
!
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
a day ago
- Time of India
Bengaluru lab fails to match woman's blood type to anyone, discovers first human with ultra-rare antigen that could revolutionize medicine
When Routine Surgery Unveiled a Rare Mystery A Blood Sample's Journey India's Rising Role in Rare Blood Research Why CRIB Changes the Game In a remarkable turn of events that is being hailed as a historic medical milestone, a 38-year-old woman from Karnataka has become the first person in the world to be identified with a previously unknown blood group antigen — officially named CRIB. According to a report from Times of India, the discovery, unveiled at the 35th Regional Congress of the International Society of Blood Transfusion (ISBT) in Milan in June 2025, is now being seen as a potential game-changer in the fields of transfusion medicine and organ transplant name CRIB isn't random — it stands for Cromer-India-Bangalore , paying homage to the antigen's family system and the city where this scientific breakthrough took medical mystery began in an unsuspecting operation theatre. Admitted for cardiac surgery in Kolar district, the patient, believed to have the widely common O Rh+ blood group, was expected to receive a standard transfusion. But in a shocking twist, her blood reacted adversely to all compatible O-positive donor should have been a routine procedure soon spiraled into a global medical investigation. With every available unit failing the compatibility test, the hospital escalated the case to the Advanced Immunohematology Reference Laboratory at Rotary Bangalore TTK Blood Centre.'We found her blood was panreactive — it reacted with every single donor sample,' said Dr. Ankit Mathur of the Rotary Centre. 'Even 20 of her closest family members didn't match. That's when we knew this was something the world hadn't seen before.'With local testing hitting a wall, blood samples were sent overseas to the International Blood Group Reference Laboratory (IBGRL) in Bristol, UK. Ten months of meticulous molecular and serological testing later, researchers identified an entirely new antigen under the Cromer (CR) blood group discovery was not just a scientific revelation — it was a collaborative triumph. The CRIB antigen now enters medical history as a reference point for future studies and emergency care cases around the the life-threatening stakes, doctors managed to perform the cardiac surgery without requiring a transfusion — a risky but ultimately successful decision. The woman not only survived but ended up redefining how the world views 'universal' blood isn't the first time India has made headlines in rare blood discoveries. Dr. Mathur notes that India has previously identified and reported cases involving Rh null and In b negative types, which were presented at international platforms. However, CRIB's identification may prove even more significant due to its global further address the rising need for rare donor matches, the Rotary Bangalore TTK Blood Centre, in collaboration with Karnataka State Blood Transfusion Council, ICMR's IIH in Mumbai, and ISBT, has launched a Rare Donor Registry Rare blood groups like CRIB are often difficult to detect and nearly impossible to match in emergencies. By adding a new antigen to global databases, CRIB opens the door to improved transfusion safety protocols, enhanced compatibility testing, and better organ transplant success rates."This is not just a scientific win — it's a humanitarian one," said a representative from ISBT. 'CRIB will help protect lives where standard blood group typing fails.'
Economic Times
a day ago
- Economic Times
Bengaluru lab fails to match woman's blood type to anyone, discovers first human with ultra-rare antigen that could revolutionize medicine
iStock In a groundbreaking discovery, a woman from Karnataka has been identified with a novel blood group antigen, CRIB, unveiled at the ISBT congress in Milan. This finding, a potential game-changer for transfusion medicine and organ transplant safety, emerged after her blood reacted adversely to all compatible donor units during cardiac surgery. (Image: iStock) In a remarkable turn of events that is being hailed as a historic medical milestone, a 38-year-old woman from Karnataka has become the first person in the world to be identified with a previously unknown blood group antigen — officially named CRIB. According to a report from Times of India, the discovery, unveiled at the 35th Regional Congress of the International Society of Blood Transfusion (ISBT) in Milan in June 2025, is now being seen as a potential game-changer in the fields of transfusion medicine and organ transplant safety. The name CRIB isn't random — it stands for Cromer-India-Bangalore, paying homage to the antigen's family system and the city where this scientific breakthrough took place. The medical mystery began in an unsuspecting operation theatre. Admitted for cardiac surgery in Kolar district, the patient, believed to have the widely common O Rh+ blood group, was expected to receive a standard transfusion. But in a shocking twist, her blood reacted adversely to all compatible O-positive donor units. What should have been a routine procedure soon spiraled into a global medical investigation. With every available unit failing the compatibility test, the hospital escalated the case to the Advanced Immunohematology Reference Laboratory at Rotary Bangalore TTK Blood Centre. 'We found her blood was panreactive — it reacted with every single donor sample,' said Dr. Ankit Mathur of the Rotary Centre. 'Even 20 of her closest family members didn't match. That's when we knew this was something the world hadn't seen before.' With local testing hitting a wall, blood samples were sent overseas to the International Blood Group Reference Laboratory (IBGRL) in Bristol, UK. Ten months of meticulous molecular and serological testing later, researchers identified an entirely new antigen under the Cromer (CR) blood group system. The discovery was not just a scientific revelation — it was a collaborative triumph. The CRIB antigen now enters medical history as a reference point for future studies and emergency care cases around the globe. Despite the life-threatening stakes, doctors managed to perform the cardiac surgery without requiring a transfusion — a risky but ultimately successful decision. The woman not only survived but ended up redefining how the world views 'universal' blood types. This isn't the first time India has made headlines in rare blood discoveries. Dr. Mathur notes that India has previously identified and reported cases involving Rh null and In b negative types, which were presented at international platforms. However, CRIB's identification may prove even more significant due to its global implications. To further address the rising need for rare donor matches, the Rotary Bangalore TTK Blood Centre, in collaboration with Karnataka State Blood Transfusion Council, ICMR's IIH in Mumbai, and ISBT, has launched a Rare Donor Registry. Rare blood groups like CRIB are often difficult to detect and nearly impossible to match in emergencies. By adding a new antigen to global databases, CRIB opens the door to improved transfusion safety protocols, enhanced compatibility testing, and better organ transplant success rates. "This is not just a scientific win — it's a humanitarian one," said a representative from ISBT. 'CRIB will help protect lives where standard blood group typing fails.' v
Time of India
a day ago
- Time of India
‘With technology insurance moving from `repair and replace' to prevention'
Mark Klein, Chief Digital Officer at Ergo, leads the insurer's digitalization, marketing and global partnerships. A former telecom and consulting executive, Klein has been with Ergo for nine years. The company, which operates across Europe and Asia in health, life and P&C insurance, recently entered the US market through a $2.6 billion acquisition of digital SME insurer Next. In an interview with Times of India, Klein speaks of how with a goal of becoming the leading digital insurer in its core markets by 2025, Ergo is deploying technologies such as process mining, AI, robotics and phone bots—more than 500 robots and 15,000 daily bot-handled calls—to boost efficiency and customer experience. How does a legacy company become a digital insurer? You've said it's more cultural than technological? That is correct. While most technologies can be deployed on top of legacy systems, the real challenge is cultural. Employees must understand what the technology does and doesn't do. We demystify the tools, give staff a stage to share success stories, and celebrate adoption—even naming robots and marking their 'birthdays.' These technologies take care of repetitive tasks, letting employees focus on complex customer needs. It was an evolutionary transformation. We reengineered core processes gradually, focusing on speed and customer centricity. How did the deployment of AI play out? We began with simple machine learning models, like email classification in 2017. That helped us prepare for broader adoption. Now, with large language models, we focus on three areas: adoption management, scaling use cases, and realizing impact. AI must move beyond pilots and deliver real business value. We have over 110 algorithms in production and a five-year plan to scale across Germany, Poland, Austria, Belgium, Spain, the UK, and Greece. In Germany, we launched "Ergo GPT," a secure ChatGPT-style tool for employees. About 60% of staff use it daily. We also use gen AI to convert unstructured broker emails into structured data and to make internal product documentation searchable using a retrieval augmented generation (RAG) model. How is process mining helping the company? Process mining offers transparency. It helps identify inefficiencies and manual bottlenecks. It creates you the full transparency of a process because it takes the log files out of your IT systems and with that really shows you the full transparency of your process. How long did it take? Which were the different steps? And you see immediately where you still have a lot of manual work, where you have working times, where your process is not so straight. Sometimes you think oh, it's a very easy process. And then you. But you have many, many permutations of that. And with that you can see how to adjust the process, how to further automate the process that you get with process mining. Is Ergo outsourcing to India? Yes, we have our service hub here, our nearshoring location for Ergo Technology Services India (ETS) in Mumbai. The team is over 600 and growing. ETS supports digital initiatives across the group. With digitisation happening at the same time as genome sequencing and predictive analysis in health and telematic insurance in motor, is insurance now more about managing risk than just calculating probability? Both matter. We're moving from "repair and replace" to prevention. In health, that means encouraging healthier lifestyles. In motor, telematics helps avoid accidents. But prediction and probability will still play a role. We are also preparing for new risks such as Cyber risks, climate-related events, and rising health issues, especially in Western Europe. These require stronger coverage and better response capabilities. With Europe having stronger privacy and data security norms. How do you ensure compliance across geographies? We follow strict governance and comply fully with GDPR. We only use customer data with explicit consent and do not use data scraping for underwriting. For rejections, there is always the concerpt of human-in-the-loop. If a claim is approved straight through, AI can handle it. But rejections always require human oversight. HDFC Ergo has launched `Here' app which goes beyond insurance and is key interface for customers. Are you looking to replicate it in other markets? We're exploring that. India's public digital infrastructure makes such services easier to implement than in Europe. Are you bringing anything new to the Indian JV? Yes. India led our group in adopting robotics in 2016. Now we exchange best practices regularly and benchmark progress across markets with four key performance indicators (KPIs): share of online sales, portal registrations, digital interactions, and availability of online products. Customer experience is the key driver. Ergo is investing over €130 million in GenAI infrastructure over the next five years—this does not including staff or operations— this is purely for tech. Stay informed with the latest business news, updates on bank holidays and public holidays . Discover stories of India's leading eco-innovators at Ecopreneur Honours 2025
